Articles | Pfizer CentreOne

How Oral Solid Coating Technologies Can Enhance Delivery Strategy - Pharmaceutical Online

Oral solid dose (OSD) remains a dominant form in drug delivery and development and there are continual advances to improve oral solid stability, integrity, and robustness through technology platforms, including coating technologies.

An Easier Pill to Swallow - Pharma Manufacturing

The increasing complexity of molecules in the drug pipeline is bringing greater challenges in formulation and scale-up. OSD manufacturers must be armed with a breadth of technology and expertise from a multidisciplinary team.

Cultivating an Efficient Scale-Up Strategy - Pharmaceutical Outsourcing

Developing drugs and preparing them for commercial markets is a challenging task. But as pharmaceutical companies manage manufacturing footprints and capital budgets, securing experienced manufacturing partners has become a priority.

Greener by Design - Contract Pharma

The reasons to adopt green chemistry are many and varied. Whatever the reason, it is likely green chemistry principles are being applied to facilitate process change—wherever it may come from. Green chemistry just makes sense, economically, for the environment, and especially for safety.

Contract Manufacturing Roundtable - European Pharmaceutical Manufacturing

Contract manufacturers, like Pfizer CentreOne, serve as reliable partners for their customers, offering expertise that is not available in-house to guide a drug securely and efficiently from development to commercial manufacture.

Tom Wilson discusses better drug manufacturing strategies with Contract Pharma

Contract Pharma sat down with Tom Wilson, VP, Global Contract Manufacturing Lead at Pfizer CentreOne, to discuss how today’s biopharma companies are turning to their contractors for long-term collaboration and support.

Pfizer CentreOne's JoyL Silva comments on the evolution of outsourcing in the pharmaceutical industry with Contract Pharma

Contract Pharma sat down with Pfizer CentreOnes’ general manager, JoyL Silva, and other industry leaders to consider how business operations have evolved to accommodate changing industry need and what we can expect for the future of the industry and outsourcing.

JoyL Silva on the benefits of the integrated CDMO model with European Pharmaceutical Manufacturing

The European Pharmaceutical Manufacturer sat down with JoyL Silva, former General Manager of Pfizer CentreOne, to discuss the benefits an embedded CDMO model brings and how Pfizer CentreOne operates within one of the world’s premier biopharmaceutical companies.

Guiding Customers Through Drug Development Challenges Q&A - CPhI Online

CPhI Online sat down with JoyL to dive into what it’s like to lead an embedded CDMO within one of the largest pharmaceutical companies and where the Pfizer CentreOne business is headed.

Contract Pharma 20th Anniversary Retrospective

Accompanied by other industry leaders JoyL Silva, General Manager at Pfizer CentreOne, spoke with Contract Pharma to unpack the changes in the industry and outsourcing, what it looked like then, how it has evolved, and where it is today.

Exclusive PBOA Q&A with Pfizer CentreOne GM, JoyL Silva

Pfizer CentreOne has always offered world-class people and performance. This continues to be central to our value proposition. Potential customers aren’t contracting with just any CDMO, they’re collaborating with Pfizer’s CDMO.

API Roundtable - Pharmaceutical Outsourcing

Nicole Strauss, Pipeline and Innovation Lead at Pfizer CentreOne, took part in a roundtable with Pharmaceutical Outsourcing to discuss the key trends around Active Pharmaceutical Ingredients (APIs) with input from other industry leaders.

Insights & Resources